| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 08/16/2006 | EP1689887A2 Methods for quantitative determination of methylation density in a dna locus |
| 08/16/2006 | EP1689883A2 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization |
| 08/16/2006 | EP1689882A2 Radioactive multiplexing analytical methods |
| 08/16/2006 | EP1689879A2 Nucleic acid hybridization methods |
| 08/16/2006 | EP1689867A1 Immunization against chlamydia infection |
| 08/16/2006 | EP1689851A2 Modified polypeptides with therapeutic activity and methods of use |
| 08/16/2006 | EP1689849A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 08/16/2006 | EP1689776A2 Equine p-selectin glycoprotein ligand-1 and uses thereof |
| 08/16/2006 | EP1689766A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 08/16/2006 | EP1689764A2 Oligonucleotides labeled with a plurality of fluorophores |
| 08/16/2006 | EP1689439A2 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 08/16/2006 | EP1689430A2 Tyrosinase mutant and methods of use thereof |
| 08/16/2006 | EP1689414A1 Polynucleotides for reducing respiratory syncytial virus gene expression |
| 08/16/2006 | EP1689355A1 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 08/16/2006 | EP1689346A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 08/16/2006 | EP1627081A4 Use of jag2 expression in diagnosis of plasma cell disorders |
| 08/16/2006 | EP1581797A4 Methods for the detection, analysis and isolation of nascent proteins |
| 08/16/2006 | EP1567672A4 Expression profiling based on histocultures |
| 08/16/2006 | EP1543154A4 Abasic site endonuclease assay |
| 08/16/2006 | EP1230387B1 Assays for short sequence variants |
| 08/16/2006 | CN1819841A Methods of enhancing immune induction involving mda-7 |
| 08/16/2006 | CN1818070A Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
| 08/16/2006 | CN1817910A Bacterial-breaking process druing procedure of BCG acid powder polysaccharide and nucleic |
| 08/16/2006 | CN1269834C Process for simultaneously carrying out RNA and DNA extraction from clinical samples by employing virus cracking liquid and precipitation process |
| 08/15/2006 | US7091334 Dissolving uridine nucleotide compound in a polar, aprotic organic solvent and a hydrophobic amine; activating, reacting with second uridine compound, purifying by chromatography |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091332 For expressing in mammalian cells microbial proteins that have anti-microbial, particularly anti-staphylococcal, activity; for therapy of mastitis in ruminant animals |
| 08/15/2006 | US7091331 Nucleic acid molecules and polypeptides encoding baboon TAFI |
| 08/15/2006 | US7091329 Protein 68075 and its use for regenerating nerve cell processes |
| 08/15/2006 | US7091325 Fibrin/fibrinogen-binding conjugate |
| 08/15/2006 | US7091318 mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 08/15/2006 | US7091315 heterologous polypeptide is the Fc domain of immunoglobulins, used to stimulate biosynthesis of interferons, or for diagnosis or prophylaxis of diseases; immunostimulants |
| 08/15/2006 | US7091313 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization |
| 08/15/2006 | US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/15/2006 | US7091178 Guanylate-binding protein |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091033 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression |
| 08/15/2006 | US7091029 Preparing adeno-associated viral vectors for gene therapeutic treatment of respiratory system disorders |
| 08/15/2006 | US7091027 Transgenic amorpha-4,11-diene synthesis |
| 08/15/2006 | US7091025 Malathion carboxylesterase |
| 08/15/2006 | US7091024 Enzyme PDE XVI |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091021 Inactive variants of the human telomerase catalytic subunit |
| 08/15/2006 | US7091020 Human Jak2 kinase |
| 08/15/2006 | US7091019 The use of these proteins enables the transformation of a hop by gene manipulations as well as enables the in vitro synthesis of the secondary metabolites of a hop. |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091017 Comprises polypeptides which catalyzes action to generate glyoxylic acid or alpha -ketoaldehyde, alpha -amino acid and hydrogen peroxide by oxidizing iminodiacetic acid or a derivative thereof; clinixcal diagnosis of blood gluclose levels |
| 08/15/2006 | US7091007 Comprises nucleotide sequences coding bone morphogenic and serine/threonine receptor proteins for for identifying modulators for use in prevention and treatment of bone and/or cartilage disorders |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7091005 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 08/15/2006 | US7091003 Polypeptides having phospholipase B activity and nucleic acids encoding same |
| 08/15/2006 | US7091002 Carboxypeptidases and nucleic acids encoding same |
| 08/15/2006 | US7091000 Bacterial strains which overproduce riboflavin and methods of use thereof |
| 08/15/2006 | US7090994 Methods of screening for introduction of DNA into a target cell |
| 08/15/2006 | US7090989 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses |
| 08/15/2006 | US7090980 Method of detecting acid-fast bacteria using ribosomal RNA as target |
| 08/15/2006 | US7090978 Obtaining tissue or sample DNA or RNA from a potential tumor cell; Amplification by polymerase chain reaction; Southern hybridization or RNase A mismatch cleavage; useful in diagnosis and prognosis of cancer |
| 08/15/2006 | US7090976 Retroviral vector comprising green fluorescent reporter protein for use as diagnostic tool in genetic engineering |
| 08/15/2006 | US7090973 codes for polypeptides used for detection, prevention and prophylaxis of bacterial infections |
| 08/15/2006 | US7090972 hybridization assay using an oligonucleotide probe complementary to hybridize to a region of rRNA selected to be unique to a non-viral organism by comparing one or more variable region rRNA sequences with rRNA sequences of the organism to be detected; can distinguish between target and non-target species |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090845 Diagnosis and treatment of hepatic disorders |
| 08/15/2006 | US7090836 Vector for expressing α-L-iduronidase and method of treating MPS I by stereotactic injection into the brain of a mammal |
| 08/15/2006 | US7090834 which exhibit improved binding; site directed mutagenesis; host cells |
| 08/11/2006 | CA2596448A1 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 08/10/2006 | WO2006084226A2 Antibodies that bind to epha2 and methods of use thereof |
| 08/10/2006 | WO2006084007A2 Novel gene underlying atherosclerosis locus i |
| 08/10/2006 | WO2006083964A2 Modified fusion molecules for treatment of allergic disease |
| 08/10/2006 | WO2006083962A1 Selected compaction agents and methods and compositions for biotechnical separations |
| 08/10/2006 | WO2006083276A2 Interferon-alpha polypeptides and conjugates |
| 08/10/2006 | WO2006083253A1 Site-specific serine recombinases and methods of their use |
| 08/10/2006 | WO2006082397A1 New uses of dinucleotide polyphosphate derivatives |
| 08/10/2006 | WO2006082058A2 Cell-free translation system for the production of (chemically) modified proteins |
| 08/10/2006 | WO2006081623A1 Double-stranded oligonucleotides and uses therefor |
| 08/10/2006 | WO2006081609A1 Molecules and chimeric molecules thereof |
| 08/10/2006 | WO2006060335A3 Cellular signaling pathway based assays, reagents and kits |
| 08/10/2006 | WO2006045009A3 Triplex probe compositions and methods for polynucleotide detection |
| 08/10/2006 | WO2006042145A3 THE RICE BACTERIAL BLIGHT DISEASE RESISTANCE GENE xa5 |
| 08/10/2006 | WO2006023560A3 Eukaryotic translation initiation factor gene regulatory elements for use in plants |
| 08/10/2006 | WO2006019429A3 Methods of identifying and using agents that increase inhibition of or resistance to hcv infection |
| 08/10/2006 | WO2005118880A3 Novel dna synthesis technology with 3’-beaded oligo dna and dna polymerase |
| 08/10/2006 | WO2005115481A3 Nuclease resistant double-stranded ribonucleic acid |
| 08/10/2006 | WO2005086804A3 Modulation of ace2 expression |
| 08/10/2006 | WO2005084254A3 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription |
| 08/10/2006 | WO2005083065A1 High glyphosate-tolerant epsp synthase from halomonas variabilis and its encoding sequence |
| 08/10/2006 | WO2005077048A3 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells |
| 08/10/2006 | WO2005067646A3 Primers and probes for the detection of hiv |
| 08/10/2006 | WO2004087886A3 Modified adenoviral e1a constructs and methods of use thereof |
| 08/10/2006 | WO2004050894A3 Heart failure gene determination and therapeutic screening |
| 08/10/2006 | US20060179516 DNA of given sequence; transforming seeds and cells using expression cassettes; |
| 08/10/2006 | US20060179514 Methods for the production of multimeric protein complexes, and related compositions |
| 08/10/2006 | US20060179507 Nucleic acid encoding protein of given sequence; hydroxylation of taxoid; used in production of anti-cancer drugs paclitaxel and taxol |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060178509 Phosphoramidite activator for oligonucleotide synthesis |
| 08/10/2006 | US20060178508 Method for labeling DNA and RNA |
| 08/10/2006 | US20060178507 Fluorous oligonucleotide reagents and affinity purification of oligonucleotides |
| 08/10/2006 | US20060178506 Amino acid modified polypeptides |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
| 08/10/2006 | US20060178502 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |